Zobrazeno 1 - 7
of 7
pro vyhledávání: '"James K. Russo"'
Autor:
Kent Armeson, John Stahl, Anand K. Sharma, Tarek A. Dufan, Aaron Luebke, James K. Russo, John T. Reynolds, Daniel Grass
Publikováno v:
Journal of Cancer Therapy. :943-953
Purpose: To investigate the toxicity, survival and patterns of failure in patients with advanced lung cancer treated with intensity modulated radiation therapy (IMRT) and chemotherapy. Methods and Materials: Retrospective chart review of 68 total pat
Autor:
Annie Braseth, James K. Russo
Publikováno v:
Headneck. 39(10)
Background Porphyria is a condition of cutaneous photosensitivity. It is unclear if radiotherapy (RT) is safe in patients with porphyria. Methods We report a patient case with uncontrolled porphyria cutanea tarda treated with chemoradiation for p16-p
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 83:e75-e80
To evaluate bladder and rectal doses using two-dimensional (2D) and 3D treatment planning for vaginal cuff high-dose rate (HDR) in endometrial cancer.Ninety-one consecutive patients treated between 2000 and 2007 were evaluated. Seventy-one and 20 pat
Publikováno v:
Japanese journal of radiology. 29(7)
Central nervous system (CNS) involvement by multiple myeloma is a rare complication that occurs in less than 1% of cases. The purpose of this report is to highlight the unique presentation and treatment of a patient with CNS myelomatosis. A 58-year-o
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 84:S566
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 6, Iss 1, p 179 (2011)
Radiation Oncology, Vol 6, Iss 1, p 179 (2011)
Background To define the dosimetric coverage of level I/II axillary volumes and the lung volume irradiated in postmastectomy radiotherapy (PMRT) following tissue expander placement. Methods and Materials Twenty-three patients were identified who had
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 78:S252
clips were found to occupy the anterior margin in 28/53 (53%), posterior margin in 50/53 (94%), superior margin in 34/53 (64%), inferior margin in 25/53 (47%), medial margin in 31/53 (58%), and the lateral margin in 25/53 (47%) of seroma cavities. Of